Orchestrated codelivery of peptide antigen and adjuvant to antigen-presenting cells by using an engineered chimeric peptide enhances antitumor T-cell immunity.
Pan H, Yu S, Zhuang H, Yang H, Jiang J, Yang H, Ren S, Luo G, Yu X, Chen S, Lin Y, Sheng R, Zhang S, Yuan Q, Huang C, Zhang T, Li T, Ge S, Zhang J, Xia N.
Pan H, et al. Among authors: ge s.
Cancer Immunol Res. 2024 Apr 17. doi: 10.1158/2326-6066.CIR-23-0926. Online ahead of print.
Cancer Immunol Res. 2024.
PMID: 38631019